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CONTRIBUTION
What are the novel findings of this work?
The recent reduction in stillbirths in England and Wales
cannot be attributed solely to the introduction of the
Growth Assessment Protocol (GAP) program. The greater
decline in the stillbirth rate in Scotland, despite the low
uptake of the program, suggests that other beneficial
public health measures common to both systems are
responsible.
What are the clinical implications of this work?
Further implementation of the GAP program and use of
customized growth centiles is not warranted on the basis
of our findings.
ABSTRACT
Objective Use of the Growth Assessment Protocol (GAP)
has increased internationally under the assumption that
it reduces the stillbirth rate. The evidence for this is
limited and based largely on an ecological time-trend
study. Discordance in the uptake of the GAP program
between Scotland and England/Wales enabled us to assess
the assertion that implementation of GAP leads to a
reduced stillbirth rate.
Methods We analyzed data from the National Records
for Scotland and the Office for National Statistics on
the number of singleton maternities and stillbirths in
Scotland and in England and Wales, respectively, from
1 January 2000 to 31 December 2015. National uptake
of the GAP program over time in each of the regions
was recorded. Stillbirth rate per 1000 maternities was
calculated, according to year of delivery, and compared
between Scotland and England/Wales.
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Results During the study period, there were 870 632
singleton maternities in Scotland, of which 4243
were stillbirths, and there were 10 469 120 singleton
maternities in England and Wales, of which 51 562 were
stillbirths. There was a marked difference in uptake of the
GAP program between the two regions, with substantially
fewer maternity units in Scotland implementing the
program. Stillbirth rates were static up to 2010, with
a decline thereafter in both regions, to 3.75 (95% CI,
3.25–4.30) per 1000 maternities in Scotland and 4.30
(95% CI, 4.15–4.46) per 1000 maternities in England
and Wales in 2015. From 2010 onwards, the decline in
Scotland was faster, equating to 48 (95% CI, 47.9–48.1)
fewer stillbirths per 100 000 maternities in Scotland than
in England and Wales from 2010 to 2015 compared with
2000 to 2009.
Conclusions We observed a decline in stillbirth rate in
England and Wales, which coincided with implementation
of the GAP program. However, a concurrent decline in
stillbirth rate was observed in Scotland in the absence
of increased implementation of GAP. The secular rates
of change in stillbirth rate in England and Wales cannot
be used to infer efficacy of the GAP program. © 2020
The Authors. Ultrasound in Obstetrics & Gynecology
published by John Wiley & Sons Ltd on behalf of the
International Society of Ultrasound in Obstetrics and
Gynecology.
INTRODUCTION
There are marked disparities in stillbirth rates across
high-income countries, which likely reflects underlying
differences in risk factors between countries, but could
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd ORIGINAL PAPER
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also reflect variation in care, such as detecting and
monitoring fetal growth restriction (FGR), one of
the major causes of stillbirth1. Screening for FGR
in low-risk women in many countries is through
clinical assessment, measuring symphyseal–fundal height,
followed by targeted use of ultrasonographic fetal
biometry. A refinement in the standard approach to FGR
screening is to account for the mother’s characteristics,
so-called customization, in which the calculated weight
centile is adjusted for maternal age, weight, height,
parity and ethnicity, as well as with the conventional
adjustment for gestational age and fetal sex2. In the UK,
the promotion of customized centiles has been through
a package of care known as the Growth Assessment
Protocol (GAP) which trains midwives and healthcare
professionals in fetal growth assessment and the use of
customized centiles.
There is no robust evidence that implementation of
GAP and use of customized fetal growth charts reduce
stillbirth and, on the basis of this, they were pointedly
not recommended in the most recent National Institute
for Health and Care Excellence (NICE) guidelines on
antenatal care, with specific recommendation for further
prospective studies assessing their efficacy3. Despite this,
proponents of the program claim that GAP, along with
customized growth charts, reduce stillbirth rates through
more accurate identification of those with FGR4,5. One
of the key pieces of evidence advanced to support their
adoption was an apparent decline in stillbirth rate in
England and Wales, which coincided with increasing
implementation of the GAP program5,6. The results of
such ecological studies need to be interpreted cautiously.
These well publicized, but not evidence-based, claims have
led to widespread adoption of customized growth charts
and weight centiles by many maternity units in England
and Wales and globally, including in Australia, Europe,
New Zealand and the USA6.
The aim of this study was to compare the recent
temporal trends in stillbirth rate in England and Wales
with those in Scotland. The rationale for this approach
is that widespread implementation of the GAP program
in England and Wales predated any implementation in
Scotland. However, the health services are otherwise very
similar between the two areas. Therefore, comparing these
geographical territories can help test the plausibility of the
assertion that the increased implementation of the GAP
program in England and Wales led to a reduced rate of
stillbirth in those countries. Clarification of whether there
is a directly attributable beneficial effect is critical, as
adoption of the GAP program by many other countries is
ongoing in the belief that its use prevents stillbirth.
METHODS
Data collection
National Records for Scotland and the Office for
National Statistics provided information on the numbers
of stillbirths and maternities in Scotland and in England
and Wales, respectively, from 1 January 2000 to
31 December 2015 inclusive. Multiple pregnancy was
excluded. Additional data stratified by maternal age were
provided for both regions. Information on the number
of stillbirths attributed to congenital or chromosomal
abnormalities was collated for Scotland. No ethical
approval was required for this study.
We assessed uptake of the GAP program in Scotland
using a survey of the lead obstetrician and/or obstetric
sonographer in all maternity units. This was done using a
brief structured questionnaire that asked for information
on the timing and extent of uptake of the protocol between
January 2000 and December 2015. This questionnaire
was administered via telephone by the first author. Uptake
in England and Wales was assessed using published
information5,7.
Data analysis
Crude stillbirth rate was defined as the number of single-
ton stillbirths per 1000 singleton maternities. Standard-
ized stillbirth rate was derived from direct standardization
for maternal age to account for differences in mater-
nal age distribution between the two regions. Stillbirth
rates (crude and standardized) with 95% CI were plot-
ted against year of delivery. On visual inspection of the
time trends, there was an evident decline in stillbirth
rate. We then compared, by fitting a linear regression
model for year and region, the difference in aggregate
age-standardized stillbirth rate before and after the visual
decline, respectively, between the two populations. We
also calculated the absolute difference with 95% CI in
crude stillbirth rate between the two populations per year
and estimated the difference in the absolute number of
stillbirths per 100 000 maternities, before and after the
decline, between Scotland and England/Wales.
RESULTS
Between 1 January 2000 and 31 December 2015, there
were 10 469 120 singleton maternities in England and
Wales, of which 51 562 were stillbirths, and there were
870 632 singleton maternities in Scotland, of which
4243 were stillbirths. All 15 maternity units in Scotland
responded to our survey about the use of the GAP
program. Figure 1 compares data from the survey in
Scotland with those for England and Wales obtained from
published information5,7. There was a marked difference
in use of the GAP program for most of the study period,
with just one (7%) unit in Scotland implementing it
between 2000 and the start of 2015, compared with a
steady increase in England and Wales to 97 (68%) units
by the start of 2015. During 2015, a further five Scottish
units commenced using the GAP program; by the end of
the final year of our study period, 40% of Scottish units,
compared with 72% of those in England and Wales, were
using the GAP program.
Figure 2 and Table 1 show crude stillbirth rates with
95% CI for singleton maternities in England and Wales
and in Scotland, according to year of delivery, from
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2020; 55: 599–604.
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Figure 1 Percentage uptake of Growth Assessment Protocol (GAP)
program in maternity units in Scotland ( ) and in England and
Wales ( ), from 2000 to 2015.
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Figure 2 Crude stillbirth rate with 95% CI in Scotland ( ) and in
England and Wales ( ), according to year of delivery, from 2000 to
2015.
2000 to 2015. Figure 3 and Table 1 show the equivalent
age-standardized stillbirth rates, which do not differ
substantially from the crude rates. In both regions, the
rates were static up to 2010 with a decline thereafter.
The lowest rates were observed in 2015 (4.30 (95% CI,
4.15–4.46) per 1000 maternities in England and Wales
and 3.75 (95% CI, 3.25–4.30) per 1000 maternities in
Scotland). From 2000 to 2009, the rates were comparable
between Scotland and England/Wales (mean difference,
0.12 (95% CI, −0.06 to 0.30); P = 0.17). From 2010
onwards, the decline in stillbirth rate in Scotland was
faster than that in England and Wales (mean difference,
−0.36 (95% CI, −0.58 to −0.14); P = 0.005), equating
to 48 (95% CI, 47.9–48.1) fewer stillbirths per 100 000
maternities in Scotland than in England and Wales in
2010 to 2015, compared with in 2000 to 2009. Figure S1
shows that the percentage of stillbirths attributed to
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Figure 3 Maternal-age standardized stillbirth rate (solid lines) and
95% CI (dashed lines) in Scotland (black) and in England and
Wales (gray), according to year of delivery, from 2000 to 2015.
Table 1 Number of singleton maternities, stillbirths and stillbirth rate per 1000 maternities in Scotland and in England and Wales,
according to year of delivery, from 2000 to 2015
Scotland England and Wales
Stillbirth rate Stillbirth rate
Year
Mater-
nities
Still-
births Crude MA standardized
Mater-
nities
Still-
births Crude MA standardized Difference*
2000 51 840 279 5.38 (4.75–6.03) 5.18 (4.95–5.41) 589 788 2920 4.95 (4.77–5.13) 4.91 (4.75–5.07) 0.43 (−0.20 to 1.06)
2001 51 224 275 5.37 (4.74–6.02) 5.20 (5.02–5.39) 580 168 2887 4.98 (4.80–5.16) 5.11 (5.01–5.22) 0.33 (−0.25 to 1.03)
2002 50 032 252 5.04 (4.42–5.68) 5.22 (5.07–5.38) 581 592 3074 5.29 (5.10–5.48) 5.27 (5.18–5.37) −0.25 (−0.91 to 0.41)
2003 51 079 263 5.15 (4.56–5.80) 5.24 (5.11–5.37) 606 683 3273 5.39 (5.21–5.58) 5.35 (5.24–5.46) −0.25 (−0.91 to 0.41)
2004 52 732 296 5.61 (4.96–6.25) 5.24 (5.12–5.36) 624 207 3383 5.42 (5.24–5.60) 5.32 (5.22–5.42) 0.19 (−0.85 to 0.46)
2005 52 968 273 5.15 (4.56–5.80) 5.23 (5.11–5.35) 630 084 3222 5.11 (4.94–5.29) 5.21 (5.12–5.30) 0.04 (−0.59 to 0.67)
2006 54 240 270 4.98 (4.40–5.61) 5.20 (5.07–5.33) 652 778 3357 5.14 (4.97–5.32) 5.08 (4.98–5.17) −0.16 (−0.79 to 0.46)
2007 56 303 301 5.35 (4.71–5.93) 5.15 (5.01–5.29) 672 528 3358 4.99 (4.83–5.16) 4.97 (4.86–5.07) 0.31 (−0.25 to 0.96)
2008 58 427 302 5.17 (4.54–5.71) 5.08 (4.94–5.22) 690 442 3355 4.86 (4.70–5.03) 4.92 (4.82–5.02) 0.31 (−0.27 to 0.90)
2009 57 471 294 5.12 (4.53–5.71) 4.98 (4.84–5.12) 686 870 3399 4.95 (4.78–5.12) 4.91 (4.83–5.00) 0.17 (−0.43 to 0.77)
2010 57 204 267 4.67 (4.09–5.22) 4.85 (4.71–4.99) 704 240 3455 4.91 (4.74–5.07) 4.91 (4.82–5.00) −0.24 (−0.83 to 0.36)
2011 57 153 278 4.86 (4.29–5.45) 4.68 (4.55–4.81) 704 535 3556 5.05 (4.88–5.22) 4.87 (4.77–4.97) −0.18 (−0.79 to 0.42)
2012 56 541 257 4.55 (3.97–5.10) 4.48 (4.35–4.61) 710 133 3304 4.65 (4.50–4.81) 4.78 (4.68–4.88) −0.11 (−0.69 to 0.48)
2013 54 569 222 4.07 (3.55–4.64) 4.25 (4.10–4.40) 680 037 3078 4.53 (4.37–4.69) 4.64 (4.56–4.73) −0.46 (−0.10 to 0.13)
2014 55 194 213 3.86 (3.36–4.41) 4.01 (3.81–4.20) 676 357 3020 4.47 (4.31–4.63) 4.47 (4.37–4.57) −0.61 (−1.18 to −0.03)
2015 53 655 201 3.75 (3.25–4.30) 3.75 (3.50–4.00) 678 678 2921 4.30 (4.15–4.46) 4.28 (4.13–4.44) −0.56 (−1.13 to 0.02)
Data are given as n or rate per 1000 maternities (95% CI). *Crude stillbirth rate in Scotland compared to in England and Wales (reference).
MA, maternal-age.
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2020; 55: 599–604.
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congenital or chromosomal abnormality in Scotland
increased marginally over the study period (P-value for
trend = 0.05).
When we removed data from 2015 (i.e. when there
was an increase in the number of units adopting the
GAP program in Scotland), the results were essentially
unchanged, with 41 (95% CI, 40.9–41.1) fewer stillbirths
per 100 000 maternities in Scotland than in England and
Wales in 2010 to 2014, compared with in 2000 to 2009.
However, there was no significant trend in the number
of stillbirths attributed to congenital or chromosomal
abnormality in Scotland from 2000 to 2014 (P-value for
trend = 0.34).
DISCUSSION
The main finding of this study is that the stillbirth
rate declined both in Scotland and in England and
Wales between 2010 and 2015, despite the discrepancy
in implementation of the GAP program between the
regions. Previous studies analyzing the rate of stillbirth in
England and Wales interpreted the decline in rate as being
potentially attributable to the increasing implementation
of the GAP program because of their concurrence5; this
has been used widely to promote GAP4,5. However, our
current observations do not support this interpretation,
as there was no increase in implementation of the
GAP program in Scotland over the same period. Given
the close similarities between the healthcare systems, it
seems likely that some common factors would have
led to the fall in stillbirth rate in the two regions. As
increased implementation of the GAP program was not
common to both regions, this cannot plausibly explain
the decline.
Why might stillbirth rates be declining across the UK?
The stillbirth rate reflects a population’s quality of
maternity care and women’s health8. Therefore, the
declining trends both in England and Wales and in
Scotland, for the first time over the last 16 years, must
coincide with contemporary advances in UK antenatal
practice and/or factors related to improved maternal
health. The publication of comprehensive NICE guidance
in 2008 and the implementation of its recommendation
for routine care in pregnancy may have contributed3. The
Lancet’s Stillbirth Series, published in 2011, summarized
strategies that could lead to a reduction in stillbirth
rate in both low- and high-income countries8–10. The
smoking cessation policy, which was adopted throughout
the UK in 2006 and 200711,12, may have contributed
to the recent reduction in stillbirth rate across the UK,
including Scotland. The more marked decline in Scotland,
compared with in England and Wales, as a result of these
interventions may be, for example, due to the greater
absolute decline in smoking rate in Scotland following
the cessation policy13,14 or the greater absolute increase
in the uptake of antenatal care in the first trimester in
Scotland compared to in England (from 65% in 2011
to 82% in 2015 vs 89% in 2010 to 92% in 2015)15.
The liberal use of third-trimester ultrasound along with
Doppler studies may have been a contributing factor to
the overall declining stillbirth rate16–18.
Why might the GAP program fail to influence stillbirth
rates?
A central component of the GAP program is the
use of customized fetal growth charts, but their key
assumption that a smaller fetus is related to variations in
maternal age, parity, weight, height and ethnicity and is
physiological rather than pathological, and therefore not
at increased risk for stillbirth, may be incorrect. We have
shown previously that partial customization weakened the
association between birth-weight centile and the risk of
perinatal death at term19. Other large cohort studies have
demonstrated that customized birth-weight centiles do not
improve prediction of term stillbirth, as compared with
population-based birth-weight standards20,21. Studies that
have supported the use of customized birth-weight centiles
have included both preterm and term births22,23, with
current evidence suggesting that gestational age may
modify the associations24.
Further evidence and comparison with other studies
Assessment of the direct effect of adoption of the
GAP program has been limited6. An interinstitutional
comparison between English maternity units with high
uptake of the GAP program and those with low uptake
demonstrated a greater decline (∼ 8%) in stillbirth rate
in the former from 2007 to 20124. However, that the
stillbirth rate was initially greater in the high-uptake
regions than the national average or that in the low uptake
regions, suggests that the subsequent decline to national
average rates may have been due to standardization of
antenatal care or regression to the mean.
To date, there has been only one small controlled trial
of the GAP program, which demonstrated that the method
identified an additional 20% of small-for-gestational-age
cases, as compared with symphyseal–fundal height
measurement25, without evidence of differences in
perinatal outcome, including stillbirth, between the two
groups. Hence, NICE did not recommend GAP in their
antenatal care guideline. Assuming a high background risk
of stillbirth of 5 in 1000 maternities, we calculated that
a randomized controlled trial (RCT) comparing the GAP
program to current standardized care would require more
than 2.4 million women to be randomized to confirm a
minimal difference of 5% in stillbirth rate.
Strengths and limitations
This study used population data with 100% coverage
from two groups (covering three countries) with a marked
difference in uptake of the GAP program, but very similar
healthcare provision. We acknowledge that an ecological
study cannot infer causality at an individual level, nor
© 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd Ultrasound Obstet Gynecol 2020; 55: 599–604.
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can it take into account all the additional discrepancies
between the two populations that may contribute to
the disparity in the outcome of interest. However, our
research objective was not to assess causality. The
antenatal populations across England/Wales and Scotland
are broadly similar with respect to maternal age and
socioeconomic position26,27. We limited our analysis to
singleton pregnancy in accordance with the use of the
GAP program2 and we examined the trend in stillbirth
rate over a long time period to allow for a lag between
uptake of the GAP program and any possible impact on
stillbirth rate. We did not undertake a survey of maternity
units in England and Wales as we did in Scotland, but
we used published data5,7. That the rate of stillbirths
attributable to congenital or chromosomal abnormality
had not altered substantially in Scotland, at least until
2014, suggests that the observed reduction in stillbirth
rate is not attributable to the later introduction of routine
fetal anomaly ultrasound and termination of affected
pregnancies.
Future research
The declining trend in stillbirth rate is promising;
however, the UK still has one of the highest rates among
high-income countries. Developing efficient and accurate
strategies to identify fetuses at risk of stillbirth, and
that will benefit from early delivery, is a key priority28.
Our sample size calculations suggest that a prohibitively
large sample size would be required for a RCT of the
GAP program vs standard care29. Novel approaches to
experimental studies, such as stepped-wedge RCTs, can
be conducted to address the impact of other interventions,
with stillbirth as a primary outcome30,31.
Conclusion
Stillbirth rates in England and Wales and in Scotland have
been declining since 2010. Our findings suggest that this
trend in England and Wales cannot be attributed reliably
to implementation of the GAP program, since the decline
has not been greater than that in Scotland, in which the
uptake of GAP was low. Implementation of the GAP
program cannot be justified based on ecological studies of
the stillbirth rate in England and Wales.
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SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Figure S1 Percentage of stillbirths (95% CI) attributed to congenital or chromosomal abnormality in Scotland,
according to year of delivery, from 2000 to 2015.
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